Ledger.Open graph →
SEC Form D · filed December 1, 2022

Rezo Therapeutics, Inc

Offering
$80.1M
Sold
$14.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Norbert Bischofberger · SAN FRANCISCO, CADirectorSimeon George · SAN FRANCISCO, CADirectorGeorge Scangos · SAN FRANCISCO, CADirectorNevan Krogan · SAN FRANCISCO, CAExec · Director · PromoterTiba Aynechi · SAN FRANCISCO, CADirectorVineeta Agarwala · SAN FRANCISCO, CADirectorHani Barhoush · Abu Dhabi, C0Exec · Director · PromoterChad Chen · GARDENA, CADirectorAlexander Pattis · New York, NYDirectorSonia Johnson · Frisco, TXDirectorLauryn Hunnicutt · Frisco, TXDirectorCarolina Hernandez · Frisco, TXDirectorSourav Bandyopadhyay · SAN FRANCISCO, CAExec · PromoterAnthony Laxen · Bloomington, MNDirectorPolitan Capital Management LP · New York, NYExec · Director · PromoterGodwin Capital Group, LLC · Atlanta, GADirectorMckenzie Glandorf · Scottsdale, AZDirectorJames Guerra · Scottsdale, AZDirectorOshiogwe Braimah · Scottsdale, AZDirectorSourav Bandyopadhyay · SAN FRANCISCO, CAExec · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗